Pediatrics & Neonatology
Volume 50, Issue 3 , Pages 125-128, June 2009

Glycogen Storage Disease Type Ib: The First Case in Taiwan

  • Hui-Ju Hsiao

      Affiliations

    • Department of Pediatrics National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Hsiu-Hao Chang

      Affiliations

    • Department of Pediatrics National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Wuh-Liang Hwu

      Affiliations

    • Department of Pediatrics National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Ching-Wan Lam

      Affiliations

    • Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China
    • ,
  • Ni-Chung Lee

      Affiliations

    • Department of Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • ,
  • Yin-Hsiu Chien

      Affiliations

    • Department of Pediatrics National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Department of Medical Genetics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Medical Genetics, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan

Received 18 August 2008; received in revised form 10 November 2008; accepted 17 December 2008.

Article Outline

Glycogen storage disease (GSD) type Ib is caused by the deficiency of glucose-6-phosphate translocase activity. The elder brother of the proband died at age 20 months, and GSD Ia, a disease caused by the deficiency of glucose-6-phosphatase, was the diagnosis. The proband developed hypoglycemia shortly after birth. Dietary therapy was instituted immediately, but his growth was poor and there were repeated episodes of pyogenic infection. Neutropenia had been observed since 6 months of age, but the diagnosis of GSD Ib was established only at 18 months of age after two mutations (c.354_355insC (p. W118fsX12) and c.736T >C (p.W246R)) were detected on his SLC37A4 gene. Regular administration of G-CSF rapidly improved his health and decreased his hospital stay. Although GSD Ib is very rare in Taiwan, correct diagnosis is essential to save the lives of such patients.

Key Words:  G-CSF , glycogen storage disease type Ib , neutropenia , recurrent infection

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Chen YT . Glycogen storage diseases . In:  Scriver CS ,  Beaudet AL ,  Sly WS ,  Valle D editor. The Metabolic and Molecular Bases of Inherited Disease . Vol. 1: New York: McGraw-Hill; 2001;p. 1530–1535
  2. Lee PJ , Dixon MA , Leonard JV . Uncooked cornstarch: efficacy in type I glycogenosis . Arch Dis Child . 1996;74:546–547
  3. Matern D , Starzl TE , Arnaout W , et al.   Liver transplantation for glycogen storage disease types I, III, and IV . Eur J Pediatr . 1999;158(Suppl 2):S43–S48
  4. Kuijpers TW , Maianski NA , Tool AT , et al.   Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b) . Blood . 2003;101:5021–5024
  5. Calderwood S , Kilpatrick L , Douglas SD , et al.   Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b . Blood . 2001;97:376–382
  6. Visser G , Rake JP , Labrune P , et al.   Consensus guidelines for management of glycogen storage disease type 1b: European Study on Glycogen Storage Disease Type 1 . Eur J Pediatr . 2002;161(Suppl 1):S120–S123
  7. Chiang SC , Lee YM , Chang MH , Wang TR , Ko TM , Hwu WL . Glucose-6-phosphatase gene mutations in Taiwan Chinese patients with glycogen storage disease type Ia . J Hum Genet . 2000;45:197–199
  8. Law LK , Tang NL , Hui J , Lam CW , Fok TF . 3-methyglutaconic aciduria in a Chinese patient with glycogen storage disease Ib . J Inherit Metab Dis . 2003;26:705–709
  9. Melis D , Fulceri R , Parenti G , et al.   Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature . Eur J Pediatr . 2005;164:501–508
  10. Veiga-da-Cunha M , Gerin I , Chen YT , et al.   The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a . Eur J Hum Genet . 1999;7:717–723
  11. Visser G , Rake JP , Labrune P , et al.   Granulocyte colonystimulating factor in glycogen storage disease type 1b: results of the European Study on Glycogen Storage Disease Type 1 . Eur J Pediatr . 2002;161(Suppl 1):S83–S87
  12. Visser G , Rake JP , Fernandes J , et al.   Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I . J Pediatr . 2000;137:187–191
  13. Schroten H , Roesler J , Breidenbach T , et al.   Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib . J Pediatr . 1991;119:748–754
  14. Simmons PS , Smithson WA , Gronert GA , Haymond MW . Acute myelogenous leukemia and malignant hyperthermia in a patient with type 1b glycogen storage disease . J Pediatr . 1984;105:428–431
  15. Donadieu J , Barkaoui M , Bezard F , Bertrand Y , Pondarre C , Guibaud P . Renal carcinoma in a patient with glycogen storage disease Ib receiving long-term granulocyte colony-stimulating factor therapy . J Pediatr Hematol Oncol . 2000;22:188–189
  16. Greene HL , Slonim AE , O'Neill JA , Burr IM . Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease . N Engl J Med . 1976;294:423–425
  17. Chen YT , Cornblath M , Sidbury JB . Cornstarch therapy in type I glycogen-storage disease . N Engl J Med . 1984;310:171–175
  18. Rake JP , Visser G , Labrune P , Leonard JV , Ullrich K , Smit GP . Glycogen storage disease type I: diagnosis, management, clinical course and outcome: results of the European Study on Glycogen Storage Disease Type I (ESGSD I) . Eur J Pediatr . 2002;161(Suppl 1):S20–S34
  19. Adachi M , Shinkai M , Ohhama Y , et al.   Improved neutrophil function in a glycogen storage disease type 1b patient after liver transplantation . Eur J Pediatr . 2004;163:202–206
  20. Lachaux A , Boillot O , Stamm D , et al.   Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib . J Pediatr . 1993;123:1005–1008

PII: S1875-9572(09)60048-6

doi:10.1016/S1875-9572(09)60048-6

Pediatrics & Neonatology
Volume 50, Issue 3 , Pages 125-128, June 2009

Article Tools